Aehr Test Systems (
NASDAQ:
AEHR) will report its first-quarter fiscal 2025 financial results on April 8, 2025. The announcement will follow the market close and the earnings call will begin at 5:00 p.m. Eastern Time.
The upcoming report covers the fiscal quarter ending February 28th, 2025. Zacks Investment Research expects the company to post an EPS of $-0.02. This compares to an EPS of $-0.05 from the same quarter last year.
As of 3:35 p.m. EDT on April 7th, AEHR stock traded at $7.31, up $0.05(0.69%), with the price hovering above a key support level at $7.
Recent Financial Performance and Guidance
In July 2024, Aehr reported financial results for the fourth quarter and full fiscal year 2024.
For Q4 2024, revenue was $16.6 million, down from $22.3 million in Q4 2023. GAAP net income was $23.9 million or $0.81 per share. This included a tax benefit of $20.8 million. Non-GAAP net income was $24.7 million or $0.84 per share.
Bookings during the quarter totaled $4.0 million. The backlog stood at $7.3 million as of May 31, 2024. Effective backlog, including post-quarter orders, reached $20.8 million. For the full year 2024, Aehr recorded record revenue of $66.2 million. This was slightly higher than $65.0 million in 2023. GAAP net income for the year was $33.2 million or $1.12 per share. Non-GAAP net income reached $35.8 million or $1.21 per share.
Cash and cash equivalents were $49.2 million at the end of May 2024. This was an increase from $47.6 million at the end of February 2024. The company expects at least $70 million in revenue for fiscal 2025. It also projects a pre-tax profit of at least 10% of revenue.
Technical Analysis: Support at $7 Holds
AEHR stock is testing a crucial support zone at $7, a level that has shown buyer interest in the past. The stock is currently trading slightly above support as traders watch to see if it remains above this level after earnings.
A positive earnings report may offer more bull strength at the support and trigger a rebound. If the price rebounds, the next immediate target is a descending trendline resistance. The trendline has rejected prices to trade above it in recent months. This therefore acts as a strong point that will need positive market developments to break above.
However, if earnings disappoint and bearish pressure grows, the stock could fall below $7. A breakdown would however exposeAEHR to lower support zones and potential new lows.
NASDAQ:AEHR) will report its first-quarter fiscal 2025 financial results on April 8, 2025. The announcement will follow the market close and the earnings call will begin at 5:00 p.m. Eastern Time.The upcoming report covers the fiscal quarter ending February 28th, 2025. Zacks Investment Research expects the company to post an EPS of $-0.02. This compares to an EPS of $-0.05 from the same quarter last year.
As of 3:35 p.m. EDT on April 7th, AEHR stock traded at $7.31, up $0.05(0.69%), with the price hovering above a key support level at $7.
Recent Financial Performance and Guidance
In July 2024, Aehr reported financial results for the fourth quarter and full fiscal year 2024.
For Q4 2024, revenue was $16.6 million, down from $22.3 million in Q4 2023. GAAP net income was $23.9 million or $0.81 per share. This included a tax benefit of $20.8 million. Non-GAAP net income was $24.7 million or $0.84 per share.
Bookings during the quarter totaled $4.0 million. The backlog stood at $7.3 million as of May 31, 2024. Effective backlog, including post-quarter orders, reached $20.8 million. For the full year 2024, Aehr recorded record revenue of $66.2 million. This was slightly higher than $65.0 million in 2023. GAAP net income for the year was $33.2 million or $1.12 per share. Non-GAAP net income reached $35.8 million or $1.21 per share.
Cash and cash equivalents were $49.2 million at the end of May 2024. This was an increase from $47.6 million at the end of February 2024. The company expects at least $70 million in revenue for fiscal 2025. It also projects a pre-tax profit of at least 10% of revenue.
Technical Analysis: Support at $7 Holds
AEHR stock is testing a crucial support zone at $7, a level that has shown buyer interest in the past. The stock is currently trading slightly above support as traders watch to see if it remains above this level after earnings.
A positive earnings report may offer more bull strength at the support and trigger a rebound. If the price rebounds, the next immediate target is a descending trendline resistance. The trendline has rejected prices to trade above it in recent months. This therefore acts as a strong point that will need positive market developments to break above.
However, if earnings disappoint and bearish pressure grows, the stock could fall below $7. A breakdown would however expose
AEHR to lower support zones and potential new lows.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.